Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar;12(2):e200350.
doi: 10.1212/NXI.0000000000200350. Epub 2024 Dec 18.

Clinical and Paraclinical Characterizations, Management, and Prognosis in DPPX Antibody-Associated Encephalitis: A Systematic Review

Affiliations

Clinical and Paraclinical Characterizations, Management, and Prognosis in DPPX Antibody-Associated Encephalitis: A Systematic Review

Er-Chuang Li et al. Neurol Neuroimmunol Neuroinflamm. 2025 Mar.

Abstract

In dipeptidyl-peptidase-like protein 6 (DPPX) antibody-associated encephalitis, DPPX antibodies from serum and CSF target the extracellular subunit of the voltage-gated potassium channel 4.2. This targeting leads to a characteristic clinical triad comprising gastrointestinal symptoms (predominantly diarrhea), cognitive-psychiatric dysfunction, and manifestations of CNS hyperexcitability, with hyperekplexia being a more specific feature. This rare disease typically presents with a subacute or chronic course and often affects middle-aged and older individuals. Patients may have a weak association with certain hematologic malignancies, particularly lymphoma and chronic lymphocytic leukemia. Brain MRI typically shows normal findings or nonspecific white matter changes. DPPX antibody-associated encephalitis responds well to immunotherapy, and most patients ultimately present with a good prognosis. However, relapses can occur. To improve our understanding of this rare but treatable autoimmune encephalitis and avoid misdiagnosis, we conduct a systematic review and summarize the current knowledge of its clinical and paraclinical features, management, and prognosis.

PubMed Disclaimer

Conflict of interest statement

The authors report no relevant disclosures. Go to Neurology.org/NN for full disclosures.

Figures

Figure 1
Figure 1. Flow Diagram of Article Selection Process for This Systematic Review
Figure 2
Figure 2. Clinical Presentations of DPPX Antibody-Associated Encephalitis
AQP4 = aquaporin 4; CASPR2 = contactin-associated protein-like 2; CRMP5 = collapsin response mediator protein 5; DPPX = dipeptidyl‐peptidase‐like protein 6; GAD = glutamic acid decarboxylase; GFAP = glial fibrillary acidic protein; NMDAR = N-methyl-d-aspartate receptor; T1DM = type 1 diabetes mellitus.
Figure 3
Figure 3. Representative Brain T2/FLAIR Axial MRI of 6 Patients With DPPX Antibody-Associated Encephalitis
(A) Mild T2/FLAIR hypersignals in the bilateral hippocampus. (B) T2/FLAIR hypersignals in the bilateral temporal lobe and hippocampus. (C) Mild T2/FLAIR hypersignals in the bilateral amygdala. (D) T2/FLAIR hypersignals in the right basal ganglia and thalamus. (E) T2/FLAIR hypersignals in the left centrum semiovale. (F) Extensive T2/FLAIR hypersignals in the bilateral frontal lobe and parietal lobe. Reprinted from Xiao et al., an open access article distributed under the terms of the Creative Commons CC BY license, which does not require permission for reuse. DPPX = dipeptidyl‐peptidase‐like protein 6; FLAIR = fluid-attenuated inversion recovery.

Similar articles

Cited by

References

    1. Boronat A, Gelfand JM, Gresa-Arribas N, et al. . Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Ann Neurol. 2013;73(1):120-128. doi:10.1002/ana.23756 - DOI - PMC - PubMed
    1. Hara M, Ariño H, Petit-Pedrol M, et al. . DPPX antibody-associated encephalitis: main syndrome and antibody effects. Neurology. 2017;88(14):1340-1348. doi:10.1212/wnl.0000000000003796 - DOI - PMC - PubMed
    1. Page MJ, Moher D, Bossuyt PM, et al. . PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. doi:10.1136/bmj.n160 - DOI - PMC - PubMed
    1. Tobin WO, Lennon VA, Komorowski L, et al. . DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients. Neurology. 2014;83(20):1797-1803. doi:10.1212/wnl.0000000000000991 - DOI - PMC - PubMed
    1. Balint B, Jarius S, Nagel S, et al. . Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies. Neurology. 2014;82(17):1521-1528. doi:10.1212/wnl.0000000000000372 - DOI - PubMed

Publication types